Foresite Capital Management V, LLC
SEC CIK 1792206 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| LTGO | Latigo Biotherapeutics, Inc. | 10% | 3.41M | $2.52M | — | 2 | 2026-08-10 | 2026-08-10 |
Most active insiders at LTGO, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Foresite Capital Management V, LLC | 10% | $2.52M | — |
| 2 | Tananbaum James B. | Dir, 10% | $2.52M | — |
| 3 | 5AM Ventures VI, L.P. | 10% | — | — |
| 4 | Westlake BioPartners Fund I, L.P. | 10% | — | — |
| 5 | SEIDENBERG BETH C | Dir, 10% | — | — |
| 6 | Sanofi | 10% | — | — |
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2026-08-10 20:21 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Foresite Capital Management V, LLC | 10% | C - Cnv Deriv | $0.00 | +9.04M | 3.41M | New | $0 |
| DI | 2026-08-10 20:21 | 2026-08-10 | LTGO | Latigo Biotherapeutics, Inc. | Foresite Capital Management V, LLC | 10% | P - Purchase | $18.00 | +140.0K | 2.01M | +7% | +$2.52M |
Purchase Sale Sale after option exercise All abbreviations